Welcome back! Today, we are talking about Simtriyo, which has generated a lot of media attention recently given a newly minted FDA approval for ADHD.
References
https://pmc.ncbi.nlm.nih.gov/articles/PMC12314114/
https://pmc.ncbi.nlm.nih.gov/articles/PMC12379780/
https://pubmed.ncbi.nlm.nih.gov/31776871/
https://pubmed.ncbi.nlm.nih.gov/40619095/